Patents by Inventor Daniel Dirocco

Daniel Dirocco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10597422
    Abstract: The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: March 24, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Daniel DiRocco, Artis Klapars, Edward C. Sherer
  • Publication number: 20190144485
    Abstract: The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
    Type: Application
    Filed: January 15, 2019
    Publication date: May 16, 2019
    Inventors: Daniel DiRocco, Artis Klapars, Edward C. Sherer
  • Publication number: 20130116445
    Abstract: Provided herein are chiral triazolium catalysts useful for asymmetric C—C bond formation and processes for their preparation. Also provided are synthetic reactions in which these catalysts are used, in particular, in asymmetric C—C bond formation.
    Type: Application
    Filed: July 12, 2011
    Publication date: May 9, 2013
    Applicant: Colorado State University Research Foundation
    Inventors: Tomislav Rovis, Daniel Dirocco, Joseph Guiles